These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29218016)

  • 1. Synergistic Anti-arrhythmic Effects in Human Atria with Combined Use of Sodium Blockers and Acacetin.
    Ni H; Whittaker DG; Wang W; Giles WR; Narayan SM; Zhang H
    Front Physiol; 2017; 8():946. PubMed ID: 29218016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
    Aguilar M; Xiong F; Qi XY; Comtois P; Nattel S
    Circulation; 2015 Dec; 132(23):2203-11. PubMed ID: 26499964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model.
    Courtemanche M; Ramirez RJ; Nattel S
    Cardiovasc Res; 1999 May; 42(2):477-89. PubMed ID: 10533583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Populations of in silico myocytes and tissues reveal synergy of multiatrial-predominant K
    Ni H; Fogli Iseppe A; Giles WR; Narayan SM; Zhang H; Edwards AG; Morotti S; Grandi E
    Br J Pharmacol; 2020 Oct; 177(19):4497-4515. PubMed ID: 32667679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.
    Burashnikov A; Belardinelli L; Antzelevitch C
    Heart Rhythm; 2015 Apr; 12(4):836-44. PubMed ID: 25546810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate-Dependent Role of I
    Aguilar M; Feng J; Vigmond E; Comtois P; Nattel S
    Biophys J; 2017 May; 112(9):1997-2010. PubMed ID: 28494969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Do Atrial-Selective Drugs Differ From Antiarrhythmic Drugs Currently Used in the Treatment of Atrial Fibrillation?
    Burashnikov A; Antzelevitch C
    J Atr Fibrillation; 2008; 1(2):98-107. PubMed ID: 21057583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approaches for pharmacological management of atrial fibrillation.
    Ehrlich JR; Nattel S
    Drugs; 2009; 69(7):757-74. PubMed ID: 19441867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria.
    Colman MA; Aslanidi OV; Kharche S; Boyett MR; Garratt C; Hancox JC; Zhang H
    J Physiol; 2013 Sep; 591(17):4249-72. PubMed ID: 23732649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes.
    Wang Z; Fermini B; Nattel S
    J Pharmacol Exp Ther; 1995 Jan; 272(1):184-96. PubMed ID: 7815332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs.
    Li GR; Wang HB; Qin GW; Jin MW; Tang Q; Sun HY; Du XL; Deng XL; Zhang XH; Chen JB; Chen L; Xu XH; Cheng LC; Chiu SW; Tse HF; Vanhoutte PM; Lau CP
    Circulation; 2008 May; 117(19):2449-57. PubMed ID: 18458165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation.
    Burashnikov A; Di Diego JM; Zygmunt AC; Belardinelli L; Antzelevitch C
    Ann N Y Acad Sci; 2008 Mar; 1123():105-12. PubMed ID: 18375582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revealing kinetics and state-dependent binding properties of I
    Ellinwood N; Dobrev D; Morotti S; Grandi E
    Chaos; 2017 Sep; 27(9):093918. PubMed ID: 28964116
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Ellinwood N; Dobrev D; Morotti S; Grandi E
    Front Pharmacol; 2017; 8():799. PubMed ID: 29163179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico assessment of genetic variation in KCNA5 reveals multiple mechanisms of human atrial arrhythmogenesis.
    Colman MA; Ni H; Liang B; Schmitt N; Zhang H
    PLoS Comput Biol; 2017 Jun; 13(6):e1005587. PubMed ID: 28622331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can inhibition of IKur promote atrial fibrillation?
    Burashnikov A; Antzelevitch C
    Heart Rhythm; 2008 Sep; 5(9):1304-9. PubMed ID: 18774108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles.
    Whittaker DG; Ni H; Benson AP; Hancox JC; Zhang H
    Front Physiol; 2017; 8():759. PubMed ID: 29085299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual Contributions of Cardiac Ion Channels on Atrial Repolarization and Reentrant Waves: A Multiscale In-Silico Study.
    Sutanto H
    J Cardiovasc Dev Dis; 2022 Jan; 9(1):. PubMed ID: 35050238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria.
    Whittaker DG; Ni H; El Harchi A; Hancox JC; Zhang H
    PLoS Comput Biol; 2017 Jun; 13(6):e1005593. PubMed ID: 28609477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation.
    Christ T; Wettwer E; Voigt N; Hála O; Radicke S; Matschke K; Várro A; Dobrev D; Ravens U
    Br J Pharmacol; 2008 Aug; 154(8):1619-30. PubMed ID: 18536759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.